Tag Archives: False Claims Act

Compliance Congress: Walking the Line

Pharma industry executives, FDA officials and Department of Justice attorneys speaking last week at CBI’s 11th annual Pharmaceutical Compliance Congress (PCC) offered solutions and threats to companies hoping to avoid enforcement actions.
Posted in Advertising, compliance, Emerging Markets, FDA, Global, Legal, Manufacturing, Marketing, People, Regulatory, Sales, Strategy, Technology | Also tagged , , , , , , , , , , , , | Leave a comment

Government Crackdown on the C-Suite

Over the past decade, the drug industry has paid tens of billions of dollars to settle state and federal lawsuits involving the False Claims Act—defrauding Medicare and Medicaid, promoting drugs for unapproved uses, paying kickbacks to doctors and pharmacies, and the like. Stories about off-label promotion of drugs with serious adverse effects and no proven […]
Posted in Legal | Also tagged , , , , | Leave a comment
  • Categories

  • Meta